Literature DB >> 16815278

Effect of hospitalization on intraocular pressure in patients with high tension and normal tension glaucoma.

Timo Haufschild1, Selim Orgül, Josef Flammer.   

Abstract

PURPOSE: To determine the effect of hospitalization on intraocular pressure (IOP) in glaucoma patients.
DESIGN: Prospective case series.
METHODS: IOP was measured on three consecutive days in 26 high-tension (HTG) and 13 normal-tension (NTGwm) glaucoma patients under IOP-lowering treatment, and in 28 normal-tension glaucoma patients without IOP-lowering treatment (NTGnm), and change was compared by analysis of variance.
RESULTS: IOP decreased significantly, but comparably, in the three groups and between right and left eyes, although, the relative change to IOP on day 1 was significantly less pronounced in the group without treatment on day 2 and 3 compared with the treated groups.
CONCLUSIONS: Glaucoma patients showed a significant decrease in IOP during hospitalization. Although this decrease was more pronounced among the treated patients, it was also present in nontreated patients. Consequently, other factors than improved compliance during hospitalization must play a role in this phenomenon.

Entities:  

Mesh:

Year:  2006        PMID: 16815278     DOI: 10.1016/j.ajo.2006.01.083

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  [Continuous 24 h monitoring of changes in intraocular pressure with the wireless contact lens sensor Triggerfish™. First results in patients].

Authors:  C Faschinger; G Mossböck
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

Review 2.  Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment.

Authors:  Anastasios G Konstas; Malik Y Kahook; Makoto Araie; Andreas Katsanos; Luciano Quaranta; Luca Rossetti; Gábor Holló; Efstathios T Detorakis; Francesco Oddone; Dimitrios G Mikropoulos; Gordon N Dutton
Journal:  Adv Ther       Date:  2018-10-20       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.